ULURU: Funding, Investors & Team (Sep 2026)
ULURU is a company that specializes in pharmaceuticals and focuses on the research, development, and commercialization of wound care and mucoadhesive film products worldwide. Their products utilize patented technologies called Nanoflex and OraDisc for drug delivery. The company offers various products including Altrazeal, a powder dressing that can transform and aid in the treatment of different types of wounds like burns and abrasions, as well as surgical or chronic wounds. They also provide Aphthasol and Aptheal for treating canker sores, as well as OraDisc A for oral conditions that require medication in gel or paste form applied to mouth lesions, and OraDisc B, a mucoadhesive disc for managing oral pain. Established in 1987, the company is headquartered in Addison, Texas.
ULURU has raised $2.2M across 1 funding round on record, the most recent an undisclosed round of $2.2M announced in Sep 2023.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
ULURU Company Profile and Key Stats
Latest funding round on record: Sep 2023.
ULURU Funding Rounds
ULURU Founders and Leadership Team
No contact details are on record for this team yet.
ULURU Funding Compared to Other Biotechnology Startups
ULURU's latest round of $2.2M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like ULURU in Biotechnology and Addison
Companies Similar to ULURU
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
ULURU Funding FAQs
What does ULURU do?
ULURU is a company that specializes in pharmaceuticals and focuses on the research, development, and commercialization of wound care and mucoadhesive film products worldwide. Their products utilize patented technologies called Nanoflex and OraDisc for drug delivery. The company offers various products including Altrazeal, a powder dressing that can transform and aid in the treatment of different types of wounds like burns and abrasions, as well as surgical or chronic wounds. They also provide Aphthasol and Aptheal for treating canker sores, as well as OraDisc A for oral conditions that require medication in gel or paste form applied to mouth lesions, and OraDisc B, a mucoadhesive disc for managing oral pain. Established in 1987, the company is headquartered in Addison, Texas.
How much funding has ULURU raised?
ULURU has raised $2.2M across 1 round on record. The most recent is an undisclosed round of $2.2M announced in Sep 2023.
When did ULURU last raise funding?
ULURU's most recent funding round on record is an undisclosed round of $2.2M, announced in Sep 2023.
Who is the CEO of ULURU?
Kerry Gray is listed as CEO at ULURU.
Where is ULURU headquartered?
ULURU is based in Addison, Texas, United States.
How many employees does ULURU have?
ULURU is in the 11-50 employee band.
How does ULURU's funding compare to other Biotechnology startups?
ULURU's latest round of $2.2M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's ULURU Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for ULURU is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.